MedPath

Shanghai SIMR Biotechnology Co.,Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2019-07-16
Last Posted Date
2024-11-29
Lead Sponsor
Shanghai SIMR Biotechnology Co., Ltd.
Target Recruit Count
64
Registration Number
NCT04021563
Locations
🇦🇺

Linear Clinical Research, Perth, Australia

© Copyright 2025. All Rights Reserved by MedPath